Trials / Completed
CompletedNCT01755299
Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
Efficacy of "5-hour Energy"®, "5-Hour Energy Decaf"®, and Caffeine for Perceived Energy and Wakefulness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- ProMedica Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The line of "5-hour Energy"® products are available over-the-counter as energy supplements. The appeal of these products involves ease of use, low caloric value, and the absence of sugar to prevent a "crash" later in the day. The definitive efficacy and potency of the products is unknown due to the lack of evidence-based clinical reports. It is suspected that the efficacy related to these products is due to the caffeine content, which was reported as 138 mg per 2-ounce bottle in an online caffeine content chart. The purpose of this randomized, double-blind, placebo controlled, four way crossover study is to evaluate the efficacy of "5-hour Energy"®, "5-Hour Energy Decaf"®, caffeine, and placebo for perceived energy and wakefulness.
Detailed description
Please see brief summary contained above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Regular "5-hour Energy" | Amount equivalent to the package commercially packaged and sold (1.93 fl. oz.) |
| OTHER | Decaf "5-hour Energy" | Commercially available "5-Hour Energy Decaf" product in the amount that is packaged (1.93 fl. oz.) |
| OTHER | Compounded concentrated caffeine liquid | Concentrated caffeine liquid has been used to compound a 135 mg/2 ounce caffeine product, which contains the same amount of caffeine as a regular "5-hour Energy" |
| OTHER | Flavored bottled water | Bottled water will be flavored and colored to serve as a placebo product for this trial. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-12-24
- Last updated
- 2013-07-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01755299. Inclusion in this directory is not an endorsement.